Assessment of phagocytic activity of polymorphonuclear leukocytes in hospitalized patients with Stages 4 and 5 chronic kidney disease

Arpana Bhide; Usha Kalawat; Sivakumar Vishnubhotla

doi:10.5455/njppp.2019.9.0930415092019

2024, Vol: 14, Issue: 4

14 / 4Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Online Publishing Date:
20 / 09 / 2019

Natl J Physiol Pharm Pharmacol. 2019; 9(12): 1172-1175

doi: 10.5455/njppp.2019.9.0930415092019

Assessment of phagocytic activity of polymorphonuclear leukocytes in hospitalized patients with Stages 4 and 5 chronic kidney disease

Arpana Bhide, Usha Kalawat, Sivakumar Vishnubhotla.

Abstract
Background: Infections are the main reason for hospitalization and the second common cause of death in chronic kidney disease (CKD) patients. Infections develop primarily as a consequence of deranged innate immunity. In this study, we assessed the efficiency of phagocytic function of polymorphonuclear (PMN) leukocytes in severe CKD patients.

Aims and Objectives: The aims of the study were (i) to assess the phagocytic index and lytic index of PMN leukocytes (PMNLs) in Stages 4 and 5 CKD patients. (ii) To compare the above indices with healthy age and sex-matched controls.

Materials and Methods: The study was carried out in 60 adults in the age group of 1860 years of which 30 were CKD patients in Stages 4 and 5 taking conservative treatment (not on dialysis) and other 30 were age and sex-matched controls. After screening for inclusion and exclusion criteria, 5 ml of venous blood was collected and taken immediately for evaluation. Phagocytic index which is the number of neutrophils positive for ingested microbes per 100 neutrophils and lytic index which is the total number of microbes per 100 cells were calculated. These are indices of neutrophil functioning.

Results: Statistically significant decrease in both phagocytic index and lytic index were found in Stages 4 and 5 CKD patients as compared to controls.

Conclusion: In the present study, we were able to establish that phagocytic capacity of PMNLs is adversely affected in severe CKD patients. This gains importance in the light of immune dysfunction being considered as a major cause of premature deaths resulting from infections in severe CKD.

Key words: Chronic Kidney Disease; Phagocytic Index; Lytic Index

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Arpana Bhide Articles by Usha Kalawat Articles by Sivakumar Vishnubhotla
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Bhide A, Kalawat U, Vishnubhotla S. Assessment of phagocytic activity of polymorphonuclear leukocytes in hospitalized patients with Stages 4 and 5 chronic kidney disease. Natl J Physiol Pharm Pharmacol. 2019; 9(12): 1172-1175. doi:10.5455/njppp.2019.9.0930415092019

Web Style

Bhide A, Kalawat U, Vishnubhotla S. Assessment of phagocytic activity of polymorphonuclear leukocytes in hospitalized patients with Stages 4 and 5 chronic kidney disease. https://www.njppp.com/?mno=64086 [Access: March 15, 2024]. doi:10.5455/njppp.2019.9.0930415092019

AMA (American Medical Association) Style

Bhide A, Kalawat U, Vishnubhotla S. Assessment of phagocytic activity of polymorphonuclear leukocytes in hospitalized patients with Stages 4 and 5 chronic kidney disease. Natl J Physiol Pharm Pharmacol. 2019; 9(12): 1172-1175. doi:10.5455/njppp.2019.9.0930415092019

Vancouver/ICMJE Style

Bhide A, Kalawat U, Vishnubhotla S. Assessment of phagocytic activity of polymorphonuclear leukocytes in hospitalized patients with Stages 4 and 5 chronic kidney disease. Natl J Physiol Pharm Pharmacol. (2019), [cited March 15, 2024]; 9(12): 1172-1175. doi:10.5455/njppp.2019.9.0930415092019

Harvard Style

Bhide, A., Kalawat, . U. & Vishnubhotla, . S. (2019) Assessment of phagocytic activity of polymorphonuclear leukocytes in hospitalized patients with Stages 4 and 5 chronic kidney disease. Natl J Physiol Pharm Pharmacol, 9 (12), 1172-1175. doi:10.5455/njppp.2019.9.0930415092019

Turabian Style

Bhide, Arpana, Usha Kalawat, and Sivakumar Vishnubhotla. 2019. Assessment of phagocytic activity of polymorphonuclear leukocytes in hospitalized patients with Stages 4 and 5 chronic kidney disease. National Journal of Physiology, Pharmacy and Pharmacology, 9 (12), 1172-1175. doi:10.5455/njppp.2019.9.0930415092019

Chicago Style

Bhide, Arpana, Usha Kalawat, and Sivakumar Vishnubhotla. "Assessment of phagocytic activity of polymorphonuclear leukocytes in hospitalized patients with Stages 4 and 5 chronic kidney disease." National Journal of Physiology, Pharmacy and Pharmacology 9 (2019), 1172-1175. doi:10.5455/njppp.2019.9.0930415092019

MLA (The Modern Language Association) Style

Bhide, Arpana, Usha Kalawat, and Sivakumar Vishnubhotla. "Assessment of phagocytic activity of polymorphonuclear leukocytes in hospitalized patients with Stages 4 and 5 chronic kidney disease." National Journal of Physiology, Pharmacy and Pharmacology 9.12 (2019), 1172-1175. Print. doi:10.5455/njppp.2019.9.0930415092019

APA (American Psychological Association) Style

Bhide, A., Kalawat, . U. & Vishnubhotla, . S. (2019) Assessment of phagocytic activity of polymorphonuclear leukocytes in hospitalized patients with Stages 4 and 5 chronic kidney disease. National Journal of Physiology, Pharmacy and Pharmacology, 9 (12), 1172-1175. doi:10.5455/njppp.2019.9.0930415092019

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article


About National Journal of Physiology, Pharmacy and Pharmacology National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal. The journal is having open access polic ... Read more. For best results, please use Internet Explorer or Google Chrome.	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272